Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, ARS Pharmaceuticals (SPRY) has a market cap of $1.47 billion USD. According to our data, ARS Pharmaceuticals is ranked No.4458 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $1.47 B |
43.45%
|
| Dec 31, 2024 | $1.03 B |
92.52%
|
| Dec 29, 2023 | $0.53 B |
-35.76%
|
| Dec 30, 2022 | $0.83 B |
28.08%
|
| Dec 31, 2021 | $0.65 B |
-85.63%
|
| Dec 31, 2020 | $4.50 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Teva Pharmaceutical Industries
TEVA
|
$15.60 B |
0.000 M
|
Israel
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
UK
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
UK
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
 AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
USA
|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
| Market Cap | = | SPRY Stock Price | * | SPRY Shares Outstanding |
| = | $14.99 | * | 98.12 M | |
| = | $1.47 B |